Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Pharmaceutical industry in the People's Republic of China Stories

2014-03-19 16:23:38

ATLANTA, March 19, 2014 /PRNewswire/ -- Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing its second New Drug Application (NDA). The NDA was originally filed with the FDA on December 23, 2013 and officially accepted for filing on February 23, 2014. Arbor's first NDA, Nymalize(®) (nimodipine) oral solution, was approved in May of last year. Arbor has a total of seven other branded projects in development consisting of both...

2014-03-19 08:23:47

DUBLIN, Mar. 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3l7xkm/global_and ) has announced the addition of the "Concise Analysis of the International and Chinese Synthesis Polypeptide Drug Industry" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) "Concise Analysis of the International and Chinese Synthesis Polypeptide Drug Industry" is a professional and in-depth study on the current state of the global...

2014-03-18 16:25:45

DUBLIN, March 18, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rs4wkl/china) has announced the addition of the "Concise Analysis of the Chinese Pharmaceutical Equipment Industry" [http://www.researchandmarkets.com/research/rs4wkl/china ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) After decades of development, China has become a major producer of pharmaceutical equipment in the...

2014-03-18 12:33:05

DALLAS, March 18, 2014 /PRNewswire/ -- The market research report "Dietary Fiber Market by Product Type (Conventional/ Novel & Soluble/ Insoluble) and Application (Food & Pharmaceuticals) - Global Trends & Forecasts to 2019", by MarketsandMarkets, projects the Dietary Fiber Market to grow from $2272.4 million in 2013 to $4,210.0 million by 2019 at a CAGR of 13.1% through 2019. North America led the global market followed by Europe and Asia-Pacific in terms of...

2014-03-15 12:20:25

DALLAS, March 15, 2014 /PRNewswire-iReach/ -- ReportsnReports.com adds "Kable's Market Opportunity Forecasts to 2018: Information Management"and "Kable's Market Opportunity Forecast to 2018: Enterprise Communications" to its store. (Photo: http://photos.prnewswire.com/prnh/20140315/MN82674) Kable's Market Opportunity Forecasts to 2018: Information Management report provides revenue opportunity forecasts in the Information Management market from 2014 to 2018, spanning four...

2014-03-14 23:01:47

Market Publishers Ltd and Emerging Markets Direct signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell research reports worked out by Emerging Markets Direct. London, UK (PRWEB) March 14, 2014 Market Publishers Ltd and Emerging Markets Direct signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell research...

2014-03-13 16:27:50

DUBLIN, Ireland, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/34kmnx/global_biosimilar) has announced the addition of the "Global Biosimilar Market Outlook 2018" [http://www.researchandmarkets.com/research/34kmnx/global_biosimilar ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global biosimilars market is at a crucial turning point, as...

2014-03-13 16:27:14

WOODCLIFF LAKE, N.J., March 13, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, March 20, 2014 at 10:00 a.m. EDT to review its results of operations for the fourth quarter and full year ended December 31, 2013. Par is privately held and currently makes certain financial information available to the public in its filings with the Securities and Exchange Commission. Par will file its financial statements for...

2014-03-13 08:29:52

MOUNTAIN VIEW, Calif. and BARCELONA, Spain, March 13, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Ferrer today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Romania. Ferrer is Alexza's commercial partner for ADASUVE in the European Union (EU), Latin America and the Commonwealth of Independent States countries. Ferrer is commercializing the product in Romania through a distribution agreement with Galenica, S.A....

2014-03-12 08:31:16

DUBLIN, March 12, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has launched, through a distribution and supply agreement, methazolamide tablets, the generic equivalent to Neptazane(TM) tablets. This product is a component of the contingent rights Perrigo received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals, LLC and its affiliates in June of last year....